Clinical Trial Update: Treatment of Post Stroke Fatigue With a Wakefulness Promoting Agent [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a wakefulness-promoting agent for post-stroke fatigue has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-stroke Fatigue
• Stroke

Drugs mentioned

• Wakefulness-promoting agent (unspecified)

Snippet

Sponsor: Herlev Hospital | Conditions: Stroke, Post Stroke Fatigue | Phase 3 | Status: TERMINATED